nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—Cisplatin—testicular cancer	0.264	0.504	CbGbCtD
Risedronate—PTGS2—Etoposide—testicular cancer	0.259	0.496	CbGbCtD
Risedronate—Paraesthesia—Cisplatin—testicular cancer	0.000643	0.00135	CcSEcCtD
Risedronate—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000643	0.00135	CcSEcCtD
Risedronate—Liver function test abnormal—Doxorubicin—testicular cancer	0.00064	0.00134	CcSEcCtD
Risedronate—Dyspnoea—Cisplatin—testicular cancer	0.000639	0.00134	CcSEcCtD
Risedronate—Skin disorder—Etoposide—testicular cancer	0.000638	0.00134	CcSEcCtD
Risedronate—Abdominal pain upper—Doxorubicin—testicular cancer	0.000633	0.00133	CcSEcCtD
Risedronate—Angina pectoris—Epirubicin—testicular cancer	0.00063	0.00132	CcSEcCtD
Risedronate—Breast disorder—Doxorubicin—testicular cancer	0.000626	0.00131	CcSEcCtD
Risedronate—Bronchitis—Epirubicin—testicular cancer	0.000622	0.00131	CcSEcCtD
Risedronate—Diarrhoea—Dactinomycin—testicular cancer	0.000621	0.0013	CcSEcCtD
Risedronate—Pneumonia—Methotrexate—testicular cancer	0.00062	0.0013	CcSEcCtD
Risedronate—Nasopharyngitis—Doxorubicin—testicular cancer	0.000619	0.0013	CcSEcCtD
Risedronate—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000619	0.0013	CcSEcCtD
Risedronate—Vomiting—Bleomycin—testicular cancer	0.000618	0.0013	CcSEcCtD
Risedronate—Infestation NOS—Methotrexate—testicular cancer	0.000617	0.00129	CcSEcCtD
Risedronate—Infestation—Methotrexate—testicular cancer	0.000617	0.00129	CcSEcCtD
Risedronate—Depression—Methotrexate—testicular cancer	0.000615	0.00129	CcSEcCtD
Risedronate—Rash—Bleomycin—testicular cancer	0.000613	0.00129	CcSEcCtD
Risedronate—Gastritis—Doxorubicin—testicular cancer	0.000613	0.00129	CcSEcCtD
Risedronate—Pain—Cisplatin—testicular cancer	0.000613	0.00129	CcSEcCtD
Risedronate—Dermatitis—Bleomycin—testicular cancer	0.000613	0.00128	CcSEcCtD
Risedronate—Hypersensitivity—Ifosfamide—testicular cancer	0.000612	0.00128	CcSEcCtD
Risedronate—Muscular weakness—Doxorubicin—testicular cancer	0.000611	0.00128	CcSEcCtD
Risedronate—Abdominal distension—Doxorubicin—testicular cancer	0.000603	0.00126	CcSEcCtD
Risedronate—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000601	0.00126	CcSEcCtD
Risedronate—Conjunctivitis—Methotrexate—testicular cancer	0.000599	0.00126	CcSEcCtD
Risedronate—Influenza—Doxorubicin—testicular cancer	0.000599	0.00126	CcSEcCtD
Risedronate—Asthma—Doxorubicin—testicular cancer	0.000599	0.00126	CcSEcCtD
Risedronate—Asthenia—Ifosfamide—testicular cancer	0.000596	0.00125	CcSEcCtD
Risedronate—Paraesthesia—Etoposide—testicular cancer	0.000589	0.00124	CcSEcCtD
Risedronate—Pruritus—Ifosfamide—testicular cancer	0.000588	0.00123	CcSEcCtD
Risedronate—Dyspnoea—Etoposide—testicular cancer	0.000585	0.00123	CcSEcCtD
Risedronate—Angina pectoris—Doxorubicin—testicular cancer	0.000583	0.00122	CcSEcCtD
Risedronate—Hepatobiliary disease—Methotrexate—testicular cancer	0.000583	0.00122	CcSEcCtD
Risedronate—Pneumonia—Epirubicin—testicular cancer	0.00058	0.00122	CcSEcCtD
Risedronate—Nausea—Bleomycin—testicular cancer	0.000578	0.00121	CcSEcCtD
Risedronate—Infestation NOS—Epirubicin—testicular cancer	0.000577	0.00121	CcSEcCtD
Risedronate—Infestation—Epirubicin—testicular cancer	0.000577	0.00121	CcSEcCtD
Risedronate—Vomiting—Dactinomycin—testicular cancer	0.000577	0.00121	CcSEcCtD
Risedronate—Bronchitis—Doxorubicin—testicular cancer	0.000576	0.00121	CcSEcCtD
Risedronate—Rash—Dactinomycin—testicular cancer	0.000572	0.0012	CcSEcCtD
Risedronate—Diarrhoea—Ifosfamide—testicular cancer	0.000569	0.00119	CcSEcCtD
Risedronate—Gastrointestinal disorder—Etoposide—testicular cancer	0.000567	0.00119	CcSEcCtD
Risedronate—Body temperature increased—Cisplatin—testicular cancer	0.000566	0.00119	CcSEcCtD
Risedronate—Fatigue—Etoposide—testicular cancer	0.000566	0.00119	CcSEcCtD
Risedronate—Pain—Etoposide—testicular cancer	0.000561	0.00118	CcSEcCtD
Risedronate—Constipation—Etoposide—testicular cancer	0.000561	0.00118	CcSEcCtD
Risedronate—Conjunctivitis—Epirubicin—testicular cancer	0.000561	0.00118	CcSEcCtD
Risedronate—Urinary tract infection—Epirubicin—testicular cancer	0.000561	0.00118	CcSEcCtD
Risedronate—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000556	0.00117	CcSEcCtD
Risedronate—Haemoglobin—Methotrexate—testicular cancer	0.000556	0.00117	CcSEcCtD
Risedronate—Haemorrhage—Methotrexate—testicular cancer	0.000553	0.00116	CcSEcCtD
Risedronate—Dizziness—Ifosfamide—testicular cancer	0.00055	0.00115	CcSEcCtD
Risedronate—Pharyngitis—Methotrexate—testicular cancer	0.000549	0.00115	CcSEcCtD
Risedronate—Urinary tract disorder—Methotrexate—testicular cancer	0.000547	0.00115	CcSEcCtD
Risedronate—Hepatobiliary disease—Epirubicin—testicular cancer	0.000546	0.00114	CcSEcCtD
Risedronate—Urethral disorder—Methotrexate—testicular cancer	0.000543	0.00114	CcSEcCtD
Risedronate—Sinusitis—Epirubicin—testicular cancer	0.000541	0.00114	CcSEcCtD
Risedronate—Nausea—Dactinomycin—testicular cancer	0.000539	0.00113	CcSEcCtD
Risedronate—Pneumonia—Doxorubicin—testicular cancer	0.000537	0.00113	CcSEcCtD
Risedronate—Gastrointestinal pain—Etoposide—testicular cancer	0.000537	0.00113	CcSEcCtD
Risedronate—Infestation NOS—Doxorubicin—testicular cancer	0.000534	0.00112	CcSEcCtD
Risedronate—Infestation—Doxorubicin—testicular cancer	0.000534	0.00112	CcSEcCtD
Risedronate—Vomiting—Ifosfamide—testicular cancer	0.000528	0.00111	CcSEcCtD
Risedronate—Hypersensitivity—Cisplatin—testicular cancer	0.000528	0.00111	CcSEcCtD
Risedronate—Rash—Ifosfamide—testicular cancer	0.000524	0.0011	CcSEcCtD
Risedronate—Dermatitis—Ifosfamide—testicular cancer	0.000524	0.0011	CcSEcCtD
Risedronate—Urticaria—Etoposide—testicular cancer	0.000521	0.00109	CcSEcCtD
Risedronate—Haemoglobin—Epirubicin—testicular cancer	0.000521	0.00109	CcSEcCtD
Risedronate—Rhinitis—Epirubicin—testicular cancer	0.000519	0.00109	CcSEcCtD
Risedronate—Abdominal pain—Etoposide—testicular cancer	0.000519	0.00109	CcSEcCtD
Risedronate—Body temperature increased—Etoposide—testicular cancer	0.000519	0.00109	CcSEcCtD
Risedronate—Urinary tract infection—Doxorubicin—testicular cancer	0.000519	0.00109	CcSEcCtD
Risedronate—Conjunctivitis—Doxorubicin—testicular cancer	0.000519	0.00109	CcSEcCtD
Risedronate—Haemorrhage—Epirubicin—testicular cancer	0.000518	0.00109	CcSEcCtD
Risedronate—Eye disorder—Methotrexate—testicular cancer	0.000517	0.00108	CcSEcCtD
Risedronate—Tinnitus—Methotrexate—testicular cancer	0.000516	0.00108	CcSEcCtD
Risedronate—Asthenia—Cisplatin—testicular cancer	0.000514	0.00108	CcSEcCtD
Risedronate—Pharyngitis—Epirubicin—testicular cancer	0.000514	0.00108	CcSEcCtD
Risedronate—Cardiac disorder—Methotrexate—testicular cancer	0.000514	0.00108	CcSEcCtD
Risedronate—Urinary tract disorder—Epirubicin—testicular cancer	0.000511	0.00107	CcSEcCtD
Risedronate—Oedema peripheral—Epirubicin—testicular cancer	0.00051	0.00107	CcSEcCtD
Risedronate—Connective tissue disorder—Epirubicin—testicular cancer	0.000509	0.00107	CcSEcCtD
Risedronate—Urethral disorder—Epirubicin—testicular cancer	0.000508	0.00106	CcSEcCtD
Risedronate—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000505	0.00106	CcSEcCtD
Risedronate—Angiopathy—Methotrexate—testicular cancer	0.000502	0.00105	CcSEcCtD
Risedronate—Sinusitis—Doxorubicin—testicular cancer	0.000501	0.00105	CcSEcCtD
Risedronate—Immune system disorder—Methotrexate—testicular cancer	0.0005	0.00105	CcSEcCtD
Risedronate—Mediastinal disorder—Methotrexate—testicular cancer	0.000499	0.00105	CcSEcCtD
Risedronate—Nausea—Ifosfamide—testicular cancer	0.000494	0.00104	CcSEcCtD
Risedronate—Diarrhoea—Cisplatin—testicular cancer	0.00049	0.00103	CcSEcCtD
Risedronate—Mental disorder—Methotrexate—testicular cancer	0.000485	0.00102	CcSEcCtD
Risedronate—Eye disorder—Epirubicin—testicular cancer	0.000484	0.00102	CcSEcCtD
Risedronate—Hypersensitivity—Etoposide—testicular cancer	0.000484	0.00101	CcSEcCtD
Risedronate—Tinnitus—Epirubicin—testicular cancer	0.000483	0.00101	CcSEcCtD
Risedronate—Malnutrition—Methotrexate—testicular cancer	0.000482	0.00101	CcSEcCtD
Risedronate—Haemoglobin—Doxorubicin—testicular cancer	0.000482	0.00101	CcSEcCtD
Risedronate—Cardiac disorder—Epirubicin—testicular cancer	0.000481	0.00101	CcSEcCtD
Risedronate—Rhinitis—Doxorubicin—testicular cancer	0.00048	0.00101	CcSEcCtD
Risedronate—Haemorrhage—Doxorubicin—testicular cancer	0.000479	0.00101	CcSEcCtD
Risedronate—Pharyngitis—Doxorubicin—testicular cancer	0.000476	0.000998	CcSEcCtD
Risedronate—Urinary tract disorder—Doxorubicin—testicular cancer	0.000473	0.000993	CcSEcCtD
Risedronate—Oedema peripheral—Doxorubicin—testicular cancer	0.000472	0.00099	CcSEcCtD
Risedronate—Asthenia—Etoposide—testicular cancer	0.000471	0.000988	CcSEcCtD
Risedronate—Connective tissue disorder—Doxorubicin—testicular cancer	0.000471	0.000988	CcSEcCtD
Risedronate—Angiopathy—Epirubicin—testicular cancer	0.00047	0.000986	CcSEcCtD
Risedronate—Urethral disorder—Doxorubicin—testicular cancer	0.00047	0.000985	CcSEcCtD
Risedronate—Immune system disorder—Epirubicin—testicular cancer	0.000468	0.000981	CcSEcCtD
Risedronate—Mediastinal disorder—Epirubicin—testicular cancer	0.000467	0.000979	CcSEcCtD
Risedronate—Back pain—Methotrexate—testicular cancer	0.000466	0.000978	CcSEcCtD
Risedronate—Pruritus—Etoposide—testicular cancer	0.000464	0.000974	CcSEcCtD
Risedronate—Arrhythmia—Epirubicin—testicular cancer	0.000463	0.000971	CcSEcCtD
Risedronate—Vomiting—Cisplatin—testicular cancer	0.000456	0.000956	CcSEcCtD
Risedronate—Mental disorder—Epirubicin—testicular cancer	0.000454	0.000952	CcSEcCtD
Risedronate—Rash—Cisplatin—testicular cancer	0.000452	0.000948	CcSEcCtD
Risedronate—Dermatitis—Cisplatin—testicular cancer	0.000451	0.000947	CcSEcCtD
Risedronate—Malnutrition—Epirubicin—testicular cancer	0.000451	0.000946	CcSEcCtD
Risedronate—Diarrhoea—Etoposide—testicular cancer	0.000449	0.000942	CcSEcCtD
Risedronate—Eye disorder—Doxorubicin—testicular cancer	0.000448	0.000939	CcSEcCtD
Risedronate—Tinnitus—Doxorubicin—testicular cancer	0.000447	0.000937	CcSEcCtD
Risedronate—Anaemia—Methotrexate—testicular cancer	0.000445	0.000934	CcSEcCtD
Risedronate—Cardiac disorder—Doxorubicin—testicular cancer	0.000445	0.000933	CcSEcCtD
Risedronate—Flatulence—Epirubicin—testicular cancer	0.000444	0.000932	CcSEcCtD
Risedronate—Back pain—Epirubicin—testicular cancer	0.000436	0.000915	CcSEcCtD
Risedronate—Angiopathy—Doxorubicin—testicular cancer	0.000435	0.000912	CcSEcCtD
Risedronate—Dizziness—Etoposide—testicular cancer	0.000434	0.000911	CcSEcCtD
Risedronate—Muscle spasms—Epirubicin—testicular cancer	0.000433	0.000909	CcSEcCtD
Risedronate—Immune system disorder—Doxorubicin—testicular cancer	0.000433	0.000908	CcSEcCtD
Risedronate—Vertigo—Methotrexate—testicular cancer	0.000433	0.000908	CcSEcCtD
Risedronate—Mediastinal disorder—Doxorubicin—testicular cancer	0.000432	0.000906	CcSEcCtD
Risedronate—Arrhythmia—Doxorubicin—testicular cancer	0.000428	0.000898	CcSEcCtD
Risedronate—Nausea—Cisplatin—testicular cancer	0.000426	0.000893	CcSEcCtD
Risedronate—Cough—Methotrexate—testicular cancer	0.00042	0.000882	CcSEcCtD
Risedronate—Mental disorder—Doxorubicin—testicular cancer	0.00042	0.000881	CcSEcCtD
Risedronate—Vomiting—Etoposide—testicular cancer	0.000417	0.000875	CcSEcCtD
Risedronate—Malnutrition—Doxorubicin—testicular cancer	0.000417	0.000875	CcSEcCtD
Risedronate—Anaemia—Epirubicin—testicular cancer	0.000417	0.000874	CcSEcCtD
Risedronate—Rash—Etoposide—testicular cancer	0.000414	0.000868	CcSEcCtD
Risedronate—Dermatitis—Etoposide—testicular cancer	0.000414	0.000867	CcSEcCtD
Risedronate—Headache—Etoposide—testicular cancer	0.000411	0.000863	CcSEcCtD
Risedronate—Flatulence—Doxorubicin—testicular cancer	0.000411	0.000862	CcSEcCtD
Risedronate—Arthralgia—Methotrexate—testicular cancer	0.00041	0.00086	CcSEcCtD
Risedronate—Myalgia—Methotrexate—testicular cancer	0.00041	0.00086	CcSEcCtD
Risedronate—Chest pain—Methotrexate—testicular cancer	0.00041	0.00086	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000407	0.000854	CcSEcCtD
Risedronate—Vertigo—Epirubicin—testicular cancer	0.000405	0.00085	CcSEcCtD
Risedronate—Syncope—Epirubicin—testicular cancer	0.000404	0.000848	CcSEcCtD
Risedronate—Back pain—Doxorubicin—testicular cancer	0.000404	0.000846	CcSEcCtD
Risedronate—Muscle spasms—Doxorubicin—testicular cancer	0.000401	0.000841	CcSEcCtD
Risedronate—Loss of consciousness—Epirubicin—testicular cancer	0.000396	0.000831	CcSEcCtD
Risedronate—Cough—Epirubicin—testicular cancer	0.000393	0.000825	CcSEcCtD
Risedronate—Infection—Methotrexate—testicular cancer	0.000391	0.000819	CcSEcCtD
Risedronate—Nausea—Etoposide—testicular cancer	0.00039	0.000818	CcSEcCtD
Risedronate—Hypertension—Epirubicin—testicular cancer	0.000389	0.000816	CcSEcCtD
Risedronate—Nervous system disorder—Methotrexate—testicular cancer	0.000386	0.000809	CcSEcCtD
Risedronate—Anaemia—Doxorubicin—testicular cancer	0.000386	0.000809	CcSEcCtD
Risedronate—Chest pain—Epirubicin—testicular cancer	0.000384	0.000805	CcSEcCtD
Risedronate—Myalgia—Epirubicin—testicular cancer	0.000384	0.000805	CcSEcCtD
Risedronate—Arthralgia—Epirubicin—testicular cancer	0.000384	0.000805	CcSEcCtD
Risedronate—Anxiety—Epirubicin—testicular cancer	0.000383	0.000802	CcSEcCtD
Risedronate—Skin disorder—Methotrexate—testicular cancer	0.000382	0.000801	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000381	0.0008	CcSEcCtD
Risedronate—Dry mouth—Epirubicin—testicular cancer	0.000375	0.000787	CcSEcCtD
Risedronate—Vertigo—Doxorubicin—testicular cancer	0.000375	0.000786	CcSEcCtD
Risedronate—Syncope—Doxorubicin—testicular cancer	0.000374	0.000785	CcSEcCtD
Risedronate—Loss of consciousness—Doxorubicin—testicular cancer	0.000367	0.000769	CcSEcCtD
Risedronate—Infection—Epirubicin—testicular cancer	0.000366	0.000767	CcSEcCtD
Risedronate—Cough—Doxorubicin—testicular cancer	0.000364	0.000764	CcSEcCtD
Risedronate—Shock—Epirubicin—testicular cancer	0.000362	0.000759	CcSEcCtD
Risedronate—Nervous system disorder—Epirubicin—testicular cancer	0.000361	0.000757	CcSEcCtD
Risedronate—Hypertension—Doxorubicin—testicular cancer	0.00036	0.000755	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000358	0.000751	CcSEcCtD
Risedronate—Skin disorder—Epirubicin—testicular cancer	0.000357	0.00075	CcSEcCtD
Risedronate—Insomnia—Methotrexate—testicular cancer	0.000356	0.000746	CcSEcCtD
Risedronate—Chest pain—Doxorubicin—testicular cancer	0.000355	0.000745	CcSEcCtD
Risedronate—Arthralgia—Doxorubicin—testicular cancer	0.000355	0.000745	CcSEcCtD
Risedronate—Myalgia—Doxorubicin—testicular cancer	0.000355	0.000745	CcSEcCtD
Risedronate—Anxiety—Doxorubicin—testicular cancer	0.000354	0.000742	CcSEcCtD
Risedronate—Paraesthesia—Methotrexate—testicular cancer	0.000353	0.000741	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000353	0.00074	CcSEcCtD
Risedronate—Dyspnoea—Methotrexate—testicular cancer	0.000351	0.000735	CcSEcCtD
Risedronate—Dry mouth—Doxorubicin—testicular cancer	0.000347	0.000729	CcSEcCtD
Risedronate—Dyspepsia—Methotrexate—testicular cancer	0.000346	0.000726	CcSEcCtD
Risedronate—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000339	0.000712	CcSEcCtD
Risedronate—Fatigue—Methotrexate—testicular cancer	0.000339	0.000711	CcSEcCtD
Risedronate—Infection—Doxorubicin—testicular cancer	0.000338	0.000709	CcSEcCtD
Risedronate—Pain—Methotrexate—testicular cancer	0.000336	0.000705	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000335	0.000703	CcSEcCtD
Risedronate—Shock—Doxorubicin—testicular cancer	0.000335	0.000703	CcSEcCtD
Risedronate—Nervous system disorder—Doxorubicin—testicular cancer	0.000334	0.0007	CcSEcCtD
Risedronate—Insomnia—Epirubicin—testicular cancer	0.000333	0.000698	CcSEcCtD
Risedronate—Skin disorder—Doxorubicin—testicular cancer	0.000331	0.000694	CcSEcCtD
Risedronate—Paraesthesia—Epirubicin—testicular cancer	0.00033	0.000693	CcSEcCtD
Risedronate—Dyspnoea—Epirubicin—testicular cancer	0.000328	0.000688	CcSEcCtD
Risedronate—Dyspepsia—Epirubicin—testicular cancer	0.000324	0.000679	CcSEcCtD
Risedronate—Gastrointestinal pain—Methotrexate—testicular cancer	0.000322	0.000674	CcSEcCtD
Risedronate—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000318	0.000666	CcSEcCtD
Risedronate—Fatigue—Epirubicin—testicular cancer	0.000317	0.000665	CcSEcCtD
Risedronate—Constipation—Epirubicin—testicular cancer	0.000315	0.00066	CcSEcCtD
Risedronate—Pain—Epirubicin—testicular cancer	0.000315	0.00066	CcSEcCtD
Risedronate—Urticaria—Methotrexate—testicular cancer	0.000312	0.000655	CcSEcCtD
Risedronate—Abdominal pain—Methotrexate—testicular cancer	0.000311	0.000652	CcSEcCtD
Risedronate—Body temperature increased—Methotrexate—testicular cancer	0.000311	0.000652	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00031	0.000651	CcSEcCtD
Risedronate—Insomnia—Doxorubicin—testicular cancer	0.000308	0.000646	CcSEcCtD
Risedronate—Paraesthesia—Doxorubicin—testicular cancer	0.000306	0.000641	CcSEcCtD
Risedronate—Dyspnoea—Doxorubicin—testicular cancer	0.000304	0.000637	CcSEcCtD
Risedronate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000301	0.000631	CcSEcCtD
Risedronate—Dyspepsia—Doxorubicin—testicular cancer	0.0003	0.000629	CcSEcCtD
Risedronate—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000294	0.000617	CcSEcCtD
Risedronate—Fatigue—Doxorubicin—testicular cancer	0.000294	0.000616	CcSEcCtD
Risedronate—Urticaria—Epirubicin—testicular cancer	0.000292	0.000613	CcSEcCtD
Risedronate—Pain—Doxorubicin—testicular cancer	0.000291	0.000611	CcSEcCtD
Risedronate—Constipation—Doxorubicin—testicular cancer	0.000291	0.000611	CcSEcCtD
Risedronate—Body temperature increased—Epirubicin—testicular cancer	0.000291	0.00061	CcSEcCtD
Risedronate—Abdominal pain—Epirubicin—testicular cancer	0.000291	0.00061	CcSEcCtD
Risedronate—Hypersensitivity—Methotrexate—testicular cancer	0.00029	0.000608	CcSEcCtD
Risedronate—Asthenia—Methotrexate—testicular cancer	0.000282	0.000592	CcSEcCtD
Risedronate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000278	0.000584	CcSEcCtD
Risedronate—Pruritus—Methotrexate—testicular cancer	0.000278	0.000584	CcSEcCtD
Risedronate—Hypersensitivity—Epirubicin—testicular cancer	0.000271	0.000569	CcSEcCtD
Risedronate—Urticaria—Doxorubicin—testicular cancer	0.00027	0.000567	CcSEcCtD
Risedronate—Abdominal pain—Doxorubicin—testicular cancer	0.000269	0.000565	CcSEcCtD
Risedronate—Body temperature increased—Doxorubicin—testicular cancer	0.000269	0.000565	CcSEcCtD
Risedronate—Diarrhoea—Methotrexate—testicular cancer	0.000269	0.000564	CcSEcCtD
Risedronate—Asthenia—Epirubicin—testicular cancer	0.000264	0.000554	CcSEcCtD
Risedronate—Pruritus—Epirubicin—testicular cancer	0.00026	0.000546	CcSEcCtD
Risedronate—Dizziness—Methotrexate—testicular cancer	0.00026	0.000545	CcSEcCtD
Risedronate—Diarrhoea—Epirubicin—testicular cancer	0.000252	0.000528	CcSEcCtD
Risedronate—Hypersensitivity—Doxorubicin—testicular cancer	0.000251	0.000526	CcSEcCtD
Risedronate—Vomiting—Methotrexate—testicular cancer	0.00025	0.000524	CcSEcCtD
Risedronate—Rash—Methotrexate—testicular cancer	0.000248	0.00052	CcSEcCtD
Risedronate—Dermatitis—Methotrexate—testicular cancer	0.000248	0.00052	CcSEcCtD
Risedronate—Headache—Methotrexate—testicular cancer	0.000246	0.000517	CcSEcCtD
Risedronate—Asthenia—Doxorubicin—testicular cancer	0.000244	0.000512	CcSEcCtD
Risedronate—Dizziness—Epirubicin—testicular cancer	0.000243	0.00051	CcSEcCtD
Risedronate—Pruritus—Doxorubicin—testicular cancer	0.000241	0.000505	CcSEcCtD
Risedronate—Vomiting—Epirubicin—testicular cancer	0.000234	0.000491	CcSEcCtD
Risedronate—Nausea—Methotrexate—testicular cancer	0.000234	0.00049	CcSEcCtD
Risedronate—Diarrhoea—Doxorubicin—testicular cancer	0.000233	0.000489	CcSEcCtD
Risedronate—Rash—Epirubicin—testicular cancer	0.000232	0.000487	CcSEcCtD
Risedronate—Dermatitis—Epirubicin—testicular cancer	0.000232	0.000486	CcSEcCtD
Risedronate—Headache—Epirubicin—testicular cancer	0.000231	0.000484	CcSEcCtD
Risedronate—Dizziness—Doxorubicin—testicular cancer	0.000225	0.000472	CcSEcCtD
Risedronate—Nausea—Epirubicin—testicular cancer	0.000219	0.000458	CcSEcCtD
Risedronate—Vomiting—Doxorubicin—testicular cancer	0.000216	0.000454	CcSEcCtD
Risedronate—Rash—Doxorubicin—testicular cancer	0.000215	0.00045	CcSEcCtD
Risedronate—Dermatitis—Doxorubicin—testicular cancer	0.000214	0.00045	CcSEcCtD
Risedronate—Headache—Doxorubicin—testicular cancer	0.000213	0.000447	CcSEcCtD
Risedronate—Nausea—Doxorubicin—testicular cancer	0.000202	0.000424	CcSEcCtD
